Asia-Pacific Peptide Therapeutics Market Report 2017

  • KMI-167937
  • Sep 2017
  • 107 pages
  • Pharmaceutical
In this report, the Asia-Pacific Peptide Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Peptide Therapeutics for these regions, from 2012 to 2022 (forecast), including
China
Japan
South Korea
Taiwan
India
Southeast Asia
Australia

Asia-Pacific Peptide Therapeutics market competition by top manufacturers/players, with Peptide Therapeutics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Pfizer
Eli Lilly and Company
Bachem Holding
Amgen
Roche
GlaxoSmithKline
Novartis
Sanofi
Takeda Pharmaceutical Company
Teva Pharmaceutical

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
by Phase
Liquid Phase
Solid Phase
Hybrid Phase
by Type of Molecule
Vasopressin
Somatostatin
Calcitonin
Immunopeptide
Natriuretic
Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Peptide Therapeutics for each application, includin
Hospitals Pharmacies
Retail Pharmacies
Drug Stores
E-Commerce

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Asia-Pacific Peptide Therapeutics Market Report 2017
1 Peptide Therapeutics Overview
1.1 Product Overview and Scope of Peptide Therapeutics
1.2 Classification of Peptide Therapeutics by Product Category
1.2.1 Asia-Pacific Peptide Therapeutics Market Size (Sales) Comparison by Types (2012-2022)
1.2.2 Asia-Pacific Peptide Therapeutics Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Liquid Phase
1.2.4 Solid Phase
1.2.5 Hybrid Phase
1.3 Asia-Pacific Peptide Therapeutics Market by Application/End Users
1.3.1 Asia-Pacific Peptide Therapeutics Sales (Volume) and Market Share Comparison by Applications (2012-2022)
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.3.5 E-Commerce
1.4 Asia-Pacific Peptide Therapeutics Market by Region
1.4.1 Asia-Pacific Peptide Therapeutics Market Size (Value) Comparison by Region (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Japan Status and Prospect (2012-2022)
1.4.4 South Korea Status and Prospect (2012-2022)
1.4.5 Taiwan Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.4.7 Southeast Asia Status and Prospect (2012-2022)
1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Peptide Therapeutics (2012-2022)
1.5.1 Asia-Pacific Peptide Therapeutics Sales and Growth Rate (2012-2022)
1.5.2 Asia-Pacific Peptide Therapeutics Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Peptide Therapeutics Competition by Players/Suppliers, Region, Type and Application
2.1 Asia-Pacific Peptide Therapeutics Market Competition by Players/Suppliers
2.1.1 Asia-Pacific Peptide Therapeutics Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Asia-Pacific Peptide Therapeutics Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Peptide Therapeutics (Volume and Value) by Type
2.2.1 Asia-Pacific Peptide Therapeutics Sales and Market Share by Type (2012-2017)
2.2.2 Asia-Pacific Peptide Therapeutics Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Peptide Therapeutics (Volume) by Application
2.4 Asia-Pacific Peptide Therapeutics (Volume and Value) by Region
2.4.1 Asia-Pacific Peptide Therapeutics Sales and Market Share by Region (2012-2017)
2.4.2 Asia-Pacific Peptide Therapeutics Revenue and Market Share by Region (2012-2017)

3 China Peptide Therapeutics (Volume, Value and Sales Price)
3.1 China Peptide Therapeutics Sales and Value (2012-2017)
3.1.1 China Peptide Therapeutics Sales Volume and Growth Rate (2012-2017)
3.1.2 China Peptide Therapeutics Revenue and Growth Rate (2012-2017)
3.1.3 China Peptide Therapeutics Sales Price Trend (2012-2017)
3.2 China Peptide Therapeutics Sales Volume and Market Share by Type
3.3 China Peptide Therapeutics Sales Volume and Market Share by Application

4 Japan Peptide Therapeutics (Volume, Value and Sales Price)
4.1 Japan Peptide Therapeutics Sales and Value (2012-2017)
4.1.1 Japan Peptide Therapeutics Sales Volume and Growth Rate (2012-2017)
4.1.2 Japan Peptide Therapeutics Revenue and Growth Rate (2012-2017)
4.1.3 Japan Peptide Therapeutics Sales Price Trend (2012-2017)
4.2 Japan Peptide Therapeutics Sales Volume and Market Share by Type
4.3 Japan Peptide Therapeutics Sales Volume and Market Share by Application

5 South Korea Peptide Therapeutics (Volume, Value and Sales Price)
5.1 South Korea Peptide Therapeutics Sales and Value (2012-2017)
5.1.1 South Korea Peptide Therapeutics Sales Volume and Growth Rate (2012-2017)
5.1.2 South Korea Peptide Therapeutics Revenue and Growth Rate (2012-2017)
5.1.3 South Korea Peptide Therapeutics Sales Price Trend (2012-2017)
5.2 South Korea Peptide Therapeutics Sales Volume and Market Share by Type
5.3 South Korea Peptide Therapeutics Sales Volume and Market Share by Application

6 Taiwan Peptide Therapeutics (Volume, Value and Sales Price)
6.1 Taiwan Peptide Therapeutics Sales and Value (2012-2017)
6.1.1 Taiwan Peptide Therapeutics Sales Volume and Growth Rate (2012-2017)
6.1.2 Taiwan Peptide Therapeutics Revenue and Growth Rate (2012-2017)
6.1.3 Taiwan Peptide Therapeutics Sales Price Trend (2012-2017)
6.2 Taiwan Peptide Therapeutics Sales Volume and Market Share by Type
6.3 Taiwan Peptide Therapeutics Sales Volume and Market Share by Application

7 India Peptide Therapeutics (Volume, Value and Sales Price)
7.1 India Peptide Therapeutics Sales and Value (2012-2017)
7.1.1 India Peptide Therapeutics Sales Volume and Growth Rate (2012-2017)
7.1.2 India Peptide Therapeutics Revenue and Growth Rate (2012-2017)
7.1.3 India Peptide Therapeutics Sales Price Trend (2012-2017)
7.2 India Peptide Therapeutics Sales Volume and Market Share by Type
7.3 India Peptide Therapeutics Sales Volume and Market Share by Application

8 Southeast Asia Peptide Therapeutics (Volume, Value and Sales Price)
8.1 Southeast Asia Peptide Therapeutics Sales and Value (2012-2017)
8.1.1 Southeast Asia Peptide Therapeutics Sales Volume and Growth Rate (2012-2017)
8.1.2 Southeast Asia Peptide Therapeutics Revenue and Growth Rate (2012-2017)
8.1.3 Southeast Asia Peptide Therapeutics Sales Price Trend (2012-2017)
8.2 Southeast Asia Peptide Therapeutics Sales Volume and Market Share by Type
8.3 Southeast Asia Peptide Therapeutics Sales Volume and Market Share by Application

9 Australia Peptide Therapeutics (Volume, Value and Sales Price)
9.1 Australia Peptide Therapeutics Sales and Value (2012-2017)
9.1.1 Australia Peptide Therapeutics Sales Volume and Growth Rate (2012-2017)
9.1.2 Australia Peptide Therapeutics Revenue and Growth Rate (2012-2017)
9.1.3 Australia Peptide Therapeutics Sales Price Trend (2012-2017)
9.2 Australia Peptide Therapeutics Sales Volume and Market Share by Type
9.3 Australia Peptide Therapeutics Sales Volume and Market Share by Application

10 Asia-Pacific Peptide Therapeutics Players/Suppliers Profiles and Sales Data
10.1 Pfizer
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Peptide Therapeutics Product Category, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Pfizer Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Eli Lilly and Company
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Peptide Therapeutics Product Category, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Eli Lilly and Company Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Bachem Holding
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Peptide Therapeutics Product Category, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Bachem Holding Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Amgen
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Peptide Therapeutics Product Category, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Amgen Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Roche
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Peptide Therapeutics Product Category, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Roche Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 GlaxoSmithKline
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Peptide Therapeutics Product Category, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 GlaxoSmithKline Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 Novartis
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Peptide Therapeutics Product Category, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 Novartis Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 Sanofi
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Peptide Therapeutics Product Category, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 Sanofi Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 Takeda Pharmaceutical Company
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Peptide Therapeutics Product Category, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 Takeda Pharmaceutical Company Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 Teva Pharmaceutical
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Peptide Therapeutics Product Category, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 Teva Pharmaceutical Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview

11 Peptide Therapeutics Manufacturing Cost Analysis
11.1 Peptide Therapeutics Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Peptide Therapeutics

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Peptide Therapeutics Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Peptide Therapeutics Major Manufacturers in 2016
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 Asia-Pacific Peptide Therapeutics Market Forecast (2017-2022)
15.1 Asia-Pacific Peptide Therapeutics Sales Volume, Revenue and Price Forecast (2017-2022)
15.1.1 Asia-Pacific Peptide Therapeutics Sales Volume and Growth Rate Forecast (2017-2022)
15.1.2 Asia-Pacific Peptide Therapeutics Revenue and Growth Rate Forecast (2017-2022)
15.1.3 Asia-Pacific Peptide Therapeutics Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Peptide Therapeutics Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.1 Asia-Pacific Peptide Therapeutics Sales Volume and Growth Rate Forecast by Region (2017-2022)
15.2.2 Asia-Pacific Peptide Therapeutics Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.3 China Peptide Therapeutics Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.4 Japan Peptide Therapeutics Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.5 South Korea Peptide Therapeutics Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.6 Taiwan Peptide Therapeutics Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.7 India Peptide Therapeutics Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.8 Southeast Asia Peptide Therapeutics Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.9 Australia Peptide Therapeutics Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Peptide Therapeutics Sales, Revenue and Price Forecast by Type (2017-2022)
15.3.1 Asia-Pacific Peptide Therapeutics Sales Forecast by Type (2017-2022)
15.3.2 Asia-Pacific Peptide Therapeutics Revenue Forecast by Type (2017-2022)
15.3.3 Asia-Pacific Peptide Therapeutics Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Peptide Therapeutics Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer


Purchase this Market Research Report



Contact Us


Mannan
Mannan Shaikh
Head-Sales
mansing
Mansingh Surve
Manager-Sales
Vivek
Vivek Pandey
Assistant Manager-Sales
Roshnee
Roshnee Tendulkar
Team Lead-Sales
view